Akoya biosciences and enable medicine introduce cloud platform to power faster analysis of phenocycler-fusion data

Marlborough, mass., april 12, 2023 (globe newswire) -- akoya biosciences, inc. (nasdaq: akya) (“akoya”), the spatial biology company®, today announced they are partnering with enable medicine to introduce a cloud platform capable of significantly accelerating the analysis of high plex spatial image datasets generated by akoya's phenocycler-fusion system. demos of the cloud platform will be available at the akoya booth (#1713) at the american association for cancer research (aacr) annual meeting being held in orlando, florida, april 14-19, 2023.
AKYA Ratings Summary
AKYA Quant Ranking